Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1980;64(4):329–338. doi: 10.1007/BF01320618

Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus

G R B Skinner 1, D R Williams 1, A W Moles 1, A Sargent 1
PMCID: PMC7101888  PMID: 6249243

Summary

Pre-pubertal immunisation of mice with a formalin-inactivated type 1 and 2 herpes simplex virus vaccine conferred a level of life-long protection against primary type 2 genital infection. Protection levels were better with type 1 vaccine and strikingly influenced by vaccine dosage where a one-hundred-fold reduction from the standard vaccine dosage diminished protection to insignificant levels. Vaccine efficacy was not significantly affected by the method of virus inactivation, the number of immunisations or the age of the mouse at immunisation. Vaccination conferred better protection than previous type 2 genital infection; this may be a consequence of a higher antigenic dose, more acceptable antigenic presentation or to a perversion of the immune response in a latently infected animal to homologous virus challenge.

Keywords: Herpes Simplex, Virus Vaccine, Infected Animal, Genital Tract, Experimental Infection

Footnotes

With 6 Figures

References

  • 1.Adam E., Kaufman R. H., Melnick R. H., Levy A. H., Rawls W. E. Seroepidemiologic studies of herpes virus type 2 and carcinoma of the cervix IV. Amer. J. Epidemiol. 1974;98:77. doi: 10.1093/oxfordjournals.aje.a121541. [DOI] [PubMed] [Google Scholar]
  • 2.Anderson W. A., Kilbourne E. D. Immunization of mice with inactivated herpes simplex virus. Proc. Soc. exp. Biol. Med. 1961;107:518. doi: 10.3181/00379727-107-26673. [DOI] [PubMed] [Google Scholar]
  • 3.Asher L. V. S., Walz M. A., Notkins A. L. Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2. Am. J. Obstet. Gynecol. 1978;131:788. doi: 10.1016/0002-9378(78)90248-x. [DOI] [PubMed] [Google Scholar]
  • 4.Benda R., Dbaly V. Immunogenic properties of formalin herpes antigen prepared from cell cultures. J. Hyg., Epidemiol., Microbiol., Immunol. 1973;17:237. [PubMed] [Google Scholar]
  • 5.Duff R., Rapp F. Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature. 1971;233:48. doi: 10.1038/newbio233048a0. [DOI] [PubMed] [Google Scholar]
  • 6.Ennis F. A. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J. inf. Dis. 1973;127:632. doi: 10.1093/infdis/127.6.632. [DOI] [PubMed] [Google Scholar]
  • 7.Geder L., Skinner G. R. B. Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique. J. gen. Virol. 1971;12:179. doi: 10.1099/0022-1317-12-2-179. [DOI] [PubMed] [Google Scholar]
  • 8.Kitces E. N., Morahan P. S., Tew J. G., Murray B. K. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect. Immun. 1977;16:955. doi: 10.1128/iai.16.3.955-960.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lipchutz B. Untersuchungen über die Ätiologie der Krankheiten der Herpesgruppe. Arch. Derm. Syph. 1921;136:428. [Google Scholar]
  • 10.MacPherson I., Stoker M. Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence. Virology. 1962;16:147. doi: 10.1016/0042-6822(62)90290-8. [DOI] [PubMed] [Google Scholar]
  • 11.McKendall R. R. Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice. Infect. Immun. 1977;16:717. doi: 10.1128/iai.16.2.717-719.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McNab J. C. M. Transformation of rat embryo cells by temperature sensitive mutants of herpes simplex virus. J. gen. Virol. 1974;24:143. doi: 10.1099/0022-1317-24-1-143. [DOI] [PubMed] [Google Scholar]
  • 13.Nahmias A. J., Josey W. E., Naib Z. M., Lucé C. F., Duffey A. Antibodies toHerpesvirus hominis types 1 and 2 in humans. I. Patients with genital infections. Amer. J. Epidemiol. 1970;91:539. doi: 10.1093/oxfordjournals.aje.a121165. [DOI] [PubMed] [Google Scholar]
  • 14.Nahmias A. J., Roizman B. Infection with herpes simplex viruses 1 and 2. N. Engl. J. Med. 1973;289:719. doi: 10.1056/NEJM197310042891404. [DOI] [PubMed] [Google Scholar]
  • 15.Pauls F. P., Dowdle W. R. A serological study ofHerpesvirus hominis strains by microneutralisation tests. J. Immunol. 1967;98:941. [PubMed] [Google Scholar]
  • 16.Plummer G., Goodheart C. R., Miyagi M., Skinner G. R. B., Thouless M. E., Wildy P. Herpes simplex viruses: Discrimination of types and correlation between different characteristics. Virology. 1974;60:206. doi: 10.1016/0042-6822(74)90378-x. [DOI] [PubMed] [Google Scholar]
  • 17.Price R. W., Walz M. A., Wohlenberg C., Notkins A. L. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunisation. Science. 1975;188:938. doi: 10.1126/science.166432. [DOI] [PubMed] [Google Scholar]
  • 18.Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J. Immunol. 1976;116:35. [PubMed] [Google Scholar]
  • 19.Rawls W. E., Gardner H. L., Flanders R. W., Lowry S. P., Kaufman R. H., Melnick J. L. Genital herpes in two social groups. Amer. J. Obstet. Gynecol. 1971;110:682. doi: 10.1016/0002-9378(71)90254-7. [DOI] [PubMed] [Google Scholar]
  • 20.Russell W. C. A sensitive and precise plaque assay for herpes virus. Nature. 1962;195:1028. doi: 10.1038/1951028a0. [DOI] [PubMed] [Google Scholar]
  • 21.Sim C., Watson D. H. The role of type-specific and cross-reacting structural antigens in the neutralisation of herpes simplex virus types 1 and 2. J. gen. Virol. 1973;19:217. doi: 10.1099/0022-1317-19-2-217. [DOI] [PubMed] [Google Scholar]
  • 22.Skinner G. R. B. Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a ‘hit-and-run’ mechanism. Brit. J. exp. Pathol. 1976;57:361. [PMC free article] [PubMed] [Google Scholar]
  • 23.Skinner, G. R. B., Hartley, C. E., Moles, A. W., Williams, D. R., Buchan, A.: The preparation, efficacy and safety of a herpes simplex vaccine for human subjects. (In preparation.) [DOI] [PubMed]
  • 24.Skinner G. R. B., Taylor J., Edwards J. Precipitating antibodies to herpes simplex virus in human sera: a prevalence of antibody to common antigen (Band II) Intervirology. 1975;4:320. doi: 10.1159/000149865. [DOI] [PubMed] [Google Scholar]
  • 25.Skinner G. R. B., Thouless M. E., Edwards J., Trueman S., Gibbs A. J. Sero-relatedness of type 1 and type 2 herpes simplex virus; type-specificity of antibody response. Immunology. 1976;31:481. [PMC free article] [PubMed] [Google Scholar]
  • 26.Skinner G. R. B., Whitney J. E., Hartley C. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology; evidence towards pre-pubertal vaccination of sero-negative female subjects. Arch. Virol. 1977;54:211. doi: 10.1007/BF01314787. [DOI] [PubMed] [Google Scholar]
  • 27.Skinner G. R. B., Williams D. R., Buchan A., Whitney J., Harding M., Bodfish K. Preparation and efficacy of an inactivated sub-unit vaccine (NFU BHK) against type 2 herpes simplex virus infection. Med. Microbiol. Immunol. 1978;166:119. doi: 10.1007/BF02121141. [DOI] [PubMed] [Google Scholar]
  • 28.Vantsis J. F., Wildy P. Interaction of herpes virus and HeLa cells: comparison of cell killing and infective centre formation. Virology. 1962;17:225. doi: 10.1016/0042-6822(62)90112-5. [DOI] [PubMed] [Google Scholar]
  • 29.Walz M. A., Price R. W., Hayashi K., et al. Effect of immunization on acute and latent infection of vagino-uterine tissue with herpes simplex virus types 1 and 2. J. inf. Dis. 1977;135:744. doi: 10.1093/infdis/135.5.744. [DOI] [PubMed] [Google Scholar]
  • 30.Wildy P. Recombination with herpes simplex virus. J. gen. Microbiol. 1955;13:340. doi: 10.1099/00221287-13-2-346. [DOI] [PubMed] [Google Scholar]
  • 31.Williams D. R., Whitney J., Harding M., Bodfish K., Skinner G. R. B. Cytological evaluation of experimental type 2 herpes simplex infection in mice. Acta Cytologica. 1978;22:41. [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES